TransMedics Group Inc (TMDX) — Cash Flow Reinvestment Rate

Latest as of March 2026: 1.49x

TransMedics Group Inc (TMDX) has a Cash Flow Reinvestment Rate of 1.49x as of March 2026, reinvesting $36.66 Million (capex $36.66 Million ) from operating cash flow of $24.53 Million. Check TransMedics Group Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.49x
(Capex + Investments) / Operating CF

Total Reinvested

$36.66 Million
Capex + Investments

Operating Cash Flow

$24.53 Million
USD

Capital Expenditures

$36.66 Million
USD

TransMedics Group Inc Cash Flow Reinvestment Rate (2024–2025)

Historical reinvestment intensity for TransMedics Group Inc across 2 annual periods. Explore TransMedics Group Inc (TMDX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for TransMedics Group Inc (2024–2025)

Year-by-year capital reinvestment analysis for TransMedics Group Inc. For live market cap and broader valuation context, see TMDX market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.31x $59.25 Million $192.84 Million $59.25 Million ▼ -94.2%
2024 5.31x $259.05 Million $48.80 Million $129.74 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow